Journal article
The Evolution of Antiplatelet Therapy After Percutaneous Coronary Interventions: A 40-Year Journey
Abstract
Antiplatelet therapy has a critical role to play in the successful management of patients undergoing percutaneous coronary intervention (PCI). Over the past 40 years, a multitude of participants worldwide have been enrolled in trials evaluating the impact of antiplatelet agents on clinical outcomes. The use of aspirin in unstable angina in the Canadian Aspirin trial was key to establishing the benefit of aspirin in acute coronary syndrome. The …
Authors
Marquis-Gravel G; Robert-Halabi M; Bainey KR; Tanguay J-F; Mehta SR
Journal
Canadian Journal of Cardiology, Vol. 38, No. 10, pp. s79–s88
Publisher
Elsevier
Publication Date
October 2022
DOI
10.1016/j.cjca.2022.02.022
ISSN
0828-282X